steel7610 (@steel7610)

Check out the WHO's document titled "Global Arbovirus Initiative: preparing for the next pandemic by tackling mosquito-borne viruses with epidemic and pandemic potential" from 2024! Link: https://www.who.int/publications/i/item/9789240088948 Here's a quote from the document: "The risk of emergence and re-emergence of arboviruses with pandemic potential has increased as a global public health threat and will continue to do so in the years to come (Fig. 1). The geographical range of arboviruses will keep extending due to increased human movement, urbanization, environmental adaptation of the mosquito vectors due to climate change, and uncontrolled expansion of mosquito vector populations." Source: https://iris.who.int/bitstream/handle/10665/376630/9789240088948-eng.pdf?sequence=1 Did you know that the term "virus X" was mentioned already in 1949? Check out the article "DDT poisoning and elusive virus X; a new cause for gastro-enteritis" from 1949!!! Here's the link to the article: https://pubmed.ncbi.nlm.nih.gov/18113629/ Interesting, isn't it? So, could the history repeat itself or could the elites repeat their scenarios? In 2023, the WHO published the document titled "Operational manual on indoor residual spraying: control of vectors of malaria, Aedes-borne diseases, Chagas disease, leishmaniases and lymphatic filariasis", where they say that "In some areas, the use of DDT may be warranted." Source: See chapter 3.3.2.2 Use of DDT for IRS" in the aforementioned document Link: https://iris.who.int/bitstream/handle/10665/375978/9789240083998-eng.pdf?sequence=1 (Note: IRS = indoor residual spraying) Meanwhile, the "scientists" are already talking about the new vaccines for Dabie bandavirus (SFTS virus), vaccines for zika virus, vaccines for yellow fever, vaccines for borna virus, vaccines for oropouche virus, vaccines for west nile virus, vaccines for dengue virus, vaccines for chikungunya virus, vaccines for Crimean-Congo Hemorrhagic Fever Virus and vaccines for malaria! See the following articles: 1. "mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice" Source: https://pubmed.ncbi.nlm.nih.gov/37907507/ 2. "The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials" Source: https://pubmed.ncbi.nlm.nih.gov/36682364/ 3. According to the article "The Present and Future of Yellow Fever Vaccines", several vaccines for yellow fever are being developed. In "Table 2", the following vaccines are mentioned, among others: - "Recombinant vaccinia virus/17D YFV" - "MVA-YF and dVV-YF" - "pYF17D-16 iDNA" - "(YF) prME mRNA" Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC10818606/ 4. "Development of Vaccines against Emerging Mosquito-Vectored Arbovirus Infections" In "Table 2", the following vaccines are mentioned, among others: - VRC-WNVDNA020-00-VP, second generation (NIAID, NIH) - WN-80E (Hawaii Biotech) - HydroVax-001, hydrogen peroxide inactivated (Najit Technologies) - Formalin inactivated (Nanotherapeutics) Source: https://pubmed.ncbi.nlm.nih.gov/38250900/ 5. "Developing a universal multi-epitope protein vaccine candidate for enhanced borna virus pandemic preparedness" Source: https://pubmed.ncbi.nlm.nih.gov/39703502/ 6. "A computational approach for MHC-restricted multi-epitope vaccine design targeting Oropouche virus structural proteins" Source: https://pubmed.ncbi.nlm.nih.gov/40049311/ 7. "Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice" Source: https://pubmed.ncbi.nlm.nih.gov/34340542/ 8. According to the article "Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies", several vaccines for dengue are being developed. Among other vaccines, the following vaccines are mentioned in "Table 1": DNA vaccines: - "DENV-2 plasmid, pEII*EIII/NS1" - "DENV1 E80" mRNA vaccine encoded vaccines: - "DENVI-NS vaccine" - "prM/E mRNA-LNP vaccine" Among other Therapeutic Strategies, the following Therapeutic Strategy is mentioned in "Table 2": - "Designing of nanobodies against dengue virus proteins" Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC10458802/ 9. "FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus" Source: https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-prevent-disease-caused-chikungunya-virus 10. "An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses" Source: https://pubmed.ncbi.nlm.nih.gov/35527225/ 11. "Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice" Source: https://pubmed.ncbi.nlm.nih.gov/39702459/ 12. Clinical trial NCT05581641 titled "Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria" Source: https://clinicaltrials.gov/study/NCT05581641 #plandemic #arboviruses #mosquitoborneediseases #oropouchevirus #vaccines #nanotechnology #nanoparticle #ddtinsecticideviruspoison #virologytoxicology #severefeverwiththrombocytopeniasyndrome #sftsvirusthrombocytopenia #malaria #pandemic #zikavirus #denguevirus #chikungunyavirus #yellowfever